Recent News Releases
This section includes a wide variety of news including media releases, photo and video galleries, fact sheets and publications.
- Iglarlixi: A new once-daily fixed-ratio combination of basal insulin glargine and lixisenatide for the management of type 2 diabetes
- Alcohol and opioid use in chronic pain: A cross-sectional examination of differences in functioning based on misuse status
- An early view of real-world patient response to sacubitril/valsartan: a retrospective study of patients with heart failure with reduced ejection fraction
- Evaluation of responsiveness to reduced-dose rituximab in corticotropin/ivig/rituximab combination immunotherapy for opsoclonus-myoclonus syndrome
- Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)
PHARMACOLOGY
- Meta- analysis comparing primary percutaneous coronary intervention vs pharmacoinvasive therapy in transfer patients with st-elevation myocardial infarction
- No detectable differential microRNA expression between non-atherosclerotic arteries of type 2 diabetic patients (treated or untreated with metformin) and non-diabetic patients
- Beta blockers and chronic heart failure patients: Prognostic impact of a dose targeted beta blocker therapy vs heart rate targeted strategy
- Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: A randomized, placebo-controlled, double-blind trial
- Ticagrelor vs clopidogrel as part of dual or triple antithrombotic therapy: A systematic review and meta-analysis
CLINICAL PHARMACOLOGY
- Prophylactic cranial irradiation vs observation in radically treated stage III non–small-cell lung cancer: A randomized phase III NVALT-11/DLCRG-02 study
- Worldwide burden of cancer attributable to diabetes and high body-mass index: A comparative risk assessment
- Robotic vs conventional laparoscopic gastrectomy for gastric cancer: A retrospective cohort study
- Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT
- Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) Lenvatinib in Differentiated Cancer of the Thyroid (SELECT)
ONCOLOGY
